Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome - Wikidata - wikimedia - TriplyDB

Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome

Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome

http://www.wikidata.org/entity/Q35576639

about

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.Pain-associated biomarkers in breast cancer HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.Triple negative breast cancer: the kiss of death.Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer.Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database.Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.The tumor microenvironment and inflammatory breast cancer.Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers.An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome.Racial and Socioeconomic Disparities Are More Pronounced in Inflammatory Breast Cancer Than Other Breast Cancers.Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostars.Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostars.Survival after recurrence of stage I-III breast, colorectal, or lung cancer.Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer.The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome

P2860

Q28075322-667FBCAF-5C32-4F78-BEDE-527A49C355E3 Q33760216-6924BC82-B698-4B5A-BB8E-911D02555FC2 Q35203556-BF7097DA-B95A-4B51-819B-F94BCA52CA62 Q35422696-BC986442-3A3E-47EB-BDED-6D5F4F636CCA Q36354259-B7A09B01-E030-4DB9-887F-9891360468D3 Q36578574-53EE8945-24B6-4974-ACC4-7628FC365E33 Q38803734-E6183E83-9E87-4827-A66A-631303A2E8A4 Q38818744-503E8ACC-243C-4214-9B5C-B2E52E1BD37D Q39442392-D7DB372A-CB52-47BF-ACC9-6B30732D4973 Q40553911-34A3128B-7B0C-436F-84B9-38C40E2DF660 Q41120070-337B6BF7-4E0D-4EC6-B6D8-27B1311F61CE Q41396244-0E3B9F7B-6551-4023-A1F9-C0E113EC2091 Q42371602-C569564D-1265-4C15-A601-134FB5CDF52A Q45994048-AC041C50-379A-469B-B175-DDFE14A95602 Q46046088-C3DC34F1-2D58-4627-8C43-9C913790F6BA Q47130011-E01E2921-11B6-42C5-B8B4-3EC1D5B8549F Q47687208-D0E81C0B-3888-4EEA-9F06-ADF01F1403DA Q50528546-6E45ADB9-8247-4CD3-BA9A-45AC3351FFD1 Q54967454-378A383D-82E1-46A3-B825-112BADE61E13 Q55122090-69B124F8-AE6B-4EAC-A17C-B3CB11D6E003 Q57054849-5F70D009-1DDC-4A96-B987-A0D646C0DFFF

P2860

Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome

http://www.wikidata.org/entity/Q35576639

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Inflammatory breast cancer man ...... ecurrence pattern, and outcome

@ast

Inflammatory breast cancer man ...... ecurrence pattern, and outcome

@en

type

label

Inflammatory breast cancer man ...... ecurrence pattern, and outcome

@ast

Inflammatory breast cancer man ...... ecurrence pattern, and outcome

@en

prefLabel

Inflammatory breast cancer man ...... ecurrence pattern, and outcome

@ast

Inflammatory breast cancer man ...... ecurrence pattern, and outcome

@en

P1433

Q35576639-FE040949-5DCA-4841-8F90-00C1E6F18341

P1476

Q35576639-EE79D9D2-9996-4130-B380-1CBCEF6BD9DE

P2093

Q35576639-01DD30C9-3425-4EFE-84C5-CA699ADA5FBC

Q35576639-3D4543B0-CB80-46A5-BDD4-7E945CA42B0F

Q35576639-4455AA29-C2C6-49EC-91B2-2CDFE0EE482D

Q35576639-5260FC73-EC3B-4EF3-855F-510F8CE1B35B

Q35576639-59804C59-0F9E-4144-9F54-C64A9E702EC9

Q35576639-79A1BFEE-E628-47A8-A92A-2A5FDB4C0C07

Q35576639-EEB98617-C8E3-4597-8DAB-14CC34D5FCF7

P2860

Q35576639-018F605A-9C36-45E5-9B05-15DE37BEEF45

Q35576639-0E48F1A7-E39D-4786-AC9D-DFF22443148D

Q35576639-1DB36C06-738C-4AEE-8AB1-C115500A2A16

Q35576639-21BE3FF2-F7E4-4B51-A733-D248B13D54DC

Q35576639-42EA6C12-CA10-4CC4-9AAC-C156849A00BA

Q35576639-474740E3-0D7A-4603-96CB-5AAA0BC41988

Q35576639-4B0B2D67-FAE3-4ECE-BBFF-CC8301FDE38A

Q35576639-4C37ECF1-9862-468F-B186-9CE34CEFE0E6

Q35576639-6A1125CA-3A76-45A4-B50C-524F906D1591

Q35576639-757E0E9A-1D22-43FF-A748-20CFD835D0C5

P304

Q35576639-98AFB54E-8E97-4FCA-A6D8-486ED342A41E

P31

Q35576639-D3DEA73F-307D-4801-AF3A-F2B08FBBE94F

P356

Q35576639-3139CD4B-5032-47D7-A74D-B25E0FD9DF65

P407

Q35576639-E8511CCF-C58F-4375-BE36-AACAE9022509

P433

Q35576639-5883659D-FC19-4CF5-9D45-440F0BD17A7C

P478

Q35576639-C955B5EB-B78E-4D3E-ACF6-147A887D6527

P577

Q35576639-F1D16941-365D-4D60-9D8D-88809B4DF839

P698

Q35576639-DC6A1201-AF7C-4F24-8766-6020711C741B

P932

Q35576639-9C6DEDFC-DB29-4A55-839B-9AB5C586CA6F

P356

J.CLBC.2014.05.005

P1433

Clinical Breast Cancer

P1476

Inflammatory breast cancer man ...... ecurrence pattern, and outcome

@en

P2093

Jane C Weeks

http://www.w3.org/2001/XMLSchema#string

Jennifer M Matro

http://www.w3.org/2001/XMLSchema#string

Massimo Cristofanilli

http://www.w3.org/2001/XMLSchema#string

Melissa E Hughes

http://www.w3.org/2001/XMLSchema#string

Rebecca A Ottesen

http://www.w3.org/2001/XMLSchema#string

Tianyu Li

http://www.w3.org/2001/XMLSchema#string

Yu-Ning Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Molecular portraits of human breast tumours

Triple-Negative Breast Cancer

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

Population-based statistics for women diagnosed with inflammatory breast cancer (United States).

Clinical aspects of inflammatory breast cancer.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLBC.2014.05.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25034439

http://www.w3.org/2001/XMLSchema#string

P932

4422394

http://www.w3.org/2001/XMLSchema#string